Form D · Biotechnology

Epic Research & Diagnostics Inc

Scottsdale, AZ · CIK 0001414511

Offering snapshot reported Aug 13, 2009 · SEC filing

Reported sold
$1.91M
Offering amount: $2M
Investors reported
20
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Dec 11, 2008
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$957K$1.91MMay 14, 2009: $1,334,997.00May 14, 2009Aug 13, 2009: $1,914,997.00Aug 13, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,334,997 → $1,914,997

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 13, 2009Amendment$1,914,997$580,000vs May 14, 200920SEC filing
May 14, 2009Initial$1,334,997No comparisonNot reportedSEC filing
Oct 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-109522
Final filing

Source: Form D, filed Aug 13, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael C Hammer Director
Diana Hunt Director
Mary Ellen Mittelstaedt Director, Executive
Nancy R Rizzo Director, Executive
A Nicholas Rizzo Director
Kenneth R Waters Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9811 East Bell Rd #105
Scottsdale, AZ, 85260